Medigene AG (HMSE: MDG1)
Health Care · Biotechnology · DE
€0.01
+26.92% today · -45.9% 1Y
Medigene AG (HMSE: MDG1) operates in the Biotechnology industry within the Health Care sector. The company is valued at $110.54K and employs 87 people.
Over the last twelve months the share price has lost 45.9%, trading between 0.00 and 0.02.
Tweenvest scores Medigene AG across four factors: quality 42/100, value 58/100, growth 67/100. Its strongest factor is growth.
MDG1 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $110.54K
- Revenue (TTM)
- $7.98M
- P/E
- —
- EPS
- -1.26
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- €0.02
- 52-week low
- €0.00
- Avg volume (3M)
- —
- Shares outstanding
- 14.89M
- Employees
- 87
- Next earnings
- —
About Medigene AG
Medigene AG is presently engaged in the liquidation of its residual assets. Its prior endeavors centered on advancing T-cell therapies designed to combat cancer. The company was founded in 1994 and maintains its principal office in Munich, Germany.
- ISIN
- DE000A40ESG2
- Founded
- 1994
- Listed since
- Jun 30, 2000
- Exchange
- Hamburg Stock Exchange
- Currency
- EUR
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Biosergen AB (publ)OM: BIOSGN | $142.46K | Skr0.50 | +3.77% |
| Oxurion NVENXTBR: OXUR | $126.66K | €0.00 | -33.33% |
| Many Bright Ideas Technologies Inc.TSXV: MBI.H | $120.88K | CA$0.01 | — |
| Ocean Biomedical, Inc.OTCPK: OCEA | $116.18K | $0.00 | -16.67% |
| Synairgen plcOTCPK: SYGG.F | $110.27K | $— | — |
| Innovation Pharmaceuticals Inc.OTCPK: IPIX | $105.75K | $0.00 | +100.00% |
| ProtoKinetix, IncorporatedOTCPK: PKTX | $82.33K | $0.00 | +100.00% |
| Vincerx Pharma, Inc.OTCPK: VINC | $78.51K | $0.02 | -41.63% |
Figures last refreshed Oct 18, 2026.